Breaking News Instant updates and real-time market news.

CPB

Campbell Soup

$41.54

-0.45 (-1.07%)

14:31
08/09/18
08/09
14:31
08/09/18
14:31

Third Point builds Campbell Soup stake, prepared to push for sale, Reuters says

CPB Campbell Soup
$41.54

-0.45 (-1.07%)

06/25/18
JPMS
06/25/18
NO CHANGE
Target $67
JPMS
Overweight
Kraft, Campbell deal may not occur, but 'in the end, money talks,' says JPMorgan
On Friday night, The New York Post reported that Kraft Heinz (KHC) "is very much interested in buying Campbell (CPB) -- and believes the soup maker's management will start a sales process soon." JPMorgan analyst Ken Goldman told investors in a research note that there are arguments for a potential deal, including the use of Campbell as a "stepping stone" to a larger deal down the road, ownership of the Campbell Soup label, but arguments against it include that Campbell "does not seem to fit" in Kraft's desire to buy growth-type assets that have international expansion potential. Goldman says he "would be surprised" if Kraft wanted Campbell, as it does not solve Kraft's growth problem and is facing "numerous" internal challenges, and does not see a deal occurring. However, Goldman notes that "in the end, money talks," and a deal cannot be dismissed out of hand. Goldman has an Overweight rating and $67 price target on Kraft Heinz shares.
06/25/18
STFL
06/25/18
NO CHANGE
STFL
Hold
Campbell more likely to focus on divestitures than outright sale, says Stifel
Following a New York Post report suggested that Kraft Heinz (KHC) is interested in purchasing Campbell Soup (CPB), Stifel analyst Christopher Growe stated in a note to investors entitled "Mmm, Mmm...Maybe" that he believes Campbell will not pursue an outright sale and will instead focus on small divestitures in front of its deal for Snyder's Lance. While an acquisition of Campbell Soup could bring significant EPS accretion to Kraft Heinz, Growe also believes it would have a negative impact on Kraft's multiple as it would perpetuate the negative perceptions of the company's growth rate, he tells investors. He keeps a Buy rating on Kraft Heinz shares and a Hold rating on Campbell Soup.
06/26/18
BERN
06/26/18
NO CHANGE
BERN
Kraft Heinz buying Campbell will not solve 'perception problem,' says Bernstein
Bernstein analyst Alexia Howard note that The New York Post reported that Kraft Heinz (KHC) would be interested in buying Campbell Soup (CPB) should the company decide to put itself up for sale. Based on her accretion analysis, the analyst believes the deal could be slightly EPS dilutive before synergies, and 13%-22% accretive for Kraft Heinz after incorporating cost synergies. Despite the potential EPS accretion, Kraft Heinz buying Campbell Soup will not solve the company's "perception problem," Howard contends, adding that there seems to be a belief that the boards of potential target companies may be unwilling to sell to Kraft Heinz because of the company's poor track record of managing the top line, particularly in the U.S.
06/26/18
SBSH
06/26/18
NO CHANGE
SBSH
Buy
Citi sees 'low probability' of Campbell Soup putting itself up for sale
After the New York Post said that Kraft Heinz (KHC) would be interested in acquiring Campbell Soup (CPB), Citi analyst David Driscoll said he thinks Campbell deciding to sell itself entirely is a "low probability event" and he believes the company is more likely to pursue divestitures. However, in the low probability scenario that Campbell is put up for sale, his "unconventional pick" for a buyer is Conagra (CAG) rather than Kraft, Driscoll added. He maintains a Buy rating on Campbell Soup shares, which closed up 9% at $42.23 yesterday following the Post's report.

TODAY'S FREE FLY STORIES

07:15
02/21/19
02/21
07:15
02/21/19
07:15
General news
FX Update: The dollar lifted on ascending hopes for a U.S.-China trade deal »

FX Update: The dollar…

FOCS

Focus Financial Partners

$30.59

0.27 (0.89%)

07:14
02/21/19
02/21
07:14
02/21/19
07:14
Earnings
Focus Financial Partners reports Q4 adj. EPS 51c, consensus 50c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 12

    Mar

GPI

Group 1 Automotive

$63.62

2.05 (3.33%)

07:14
02/21/19
02/21
07:14
02/21/19
07:14
Hot Stocks
Group 1 Automotive raises share repurchase authorization to $75M »

Group 1 Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 06

    Mar

OGE

OGE Energy

$41.94

0.01 (0.02%)

07:13
02/21/19
02/21
07:13
02/21/19
07:13
Earnings
Breaking Earnings news story on OGE Energy »

OGE Energy sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

AERI

Aerie Pharmaceuticals

$39.56

-1.25 (-3.06%)

07:13
02/21/19
02/21
07:13
02/21/19
07:13
Recommendations
Aerie Pharmaceuticals analyst commentary  »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 14

    Mar

  • 18

    Mar

OGE

OGE Energy

$41.94

0.01 (0.02%)

07:12
02/21/19
02/21
07:12
02/21/19
07:12
Earnings
OGE Energy reports Q4 EPS 27c, consensus 23c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BRC

Brady

$47.35

0.59 (1.26%)

07:12
02/21/19
02/21
07:12
02/21/19
07:12
Earnings
Brady raises FY19 EPS view to $2.25-$2.35 from $2.20-$2.30, consensus $2.28 »

Backs FY19 organic sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

VRCA

Verrica Pharmaceuticals

$10.99

-0.12 (-1.08%)

07:11
02/21/19
02/21
07:11
02/21/19
07:11
Initiation
Verrica Pharmaceuticals initiated  »

Verrica Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

ARRS

Arris

$31.65

0.025 (0.08%)

07:11
02/21/19
02/21
07:11
02/21/19
07:11
Earnings
Arris reports preliminary Q4 adjusted EPS 76c, consensus 75c »

Reports Q4 preliminary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Hot Stocks
Wendy's approves new $225M share repurchase program »

At the end of 2018, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

QEP

QEP Resources

$8.19

-0.08 (-0.97%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Recommendations
QEP Resources analyst commentary  »

Elliott may push for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BRC

Brady

$47.35

0.59 (1.26%)

07:10
02/21/19
02/21
07:10
02/21/19
07:10
Earnings
Brady reports Q2 EPS 55c, consensus 52c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

AVB

AvalonBay

$194.14

-2.37 (-1.21%)

07:09
02/21/19
02/21
07:09
02/21/19
07:09
Downgrade
AvalonBay rating change  »

Citi downgrades AvalonBay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:09
02/21/19
02/21
07:09
02/21/19
07:09
Hot Stocks
Breaking Hot Stocks news story on Ardagh Group »

Ardagh Group sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Ardagh Group sees FY19 adjusted EPS $1.60-$1.75, consensus $1.76 »

2019 outlook: Full year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IRT

Independence Realty Trust

$10.71

-0.01 (-0.09%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Independence Realty sees FY19 EPS 76c-80c, may not compare to consensus 24c 

Sees FY19 CFFO 74c-78c.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Wendy's sees FY20 global systemwide sales of approximately $11.5B »

Sees FY20 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

ALB

Albemarle

$82.82

-0.305 (-0.37%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Recommendations
Albemarle analyst commentary  »

Oppenheimer says remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 27

    Feb

  • 27

    Feb

BDC

Belden

$63.83

7.19 (12.69%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Recommendations
Belden analyst commentary  »

Belden price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    May

  • 14

    May

  • 15

    May

MCRN

Milacron

$14.78

0.13 (0.89%)

07:08
02/21/19
02/21
07:08
02/21/19
07:08
Earnings
Milacron sees FY19 pro forma sales growth 0%-1%, consensus $1.28B »

In line with current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ARD

Ardagh Group

$12.98

0.32 (2.53%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Ardagh Group reports Q4 adjusted EPS 33c, consensus 28c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GIL

Gildan Activewear

$34.17

-0.17 (-0.50%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Breaking Earnings news story on Gildan Activewear »

Gildan Activewear sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

IRT

Independence Realty Trust

$10.71

-0.01 (-0.09%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Independence Realty Trust reports Q4 EPS 16c, consensus 5c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WEN

Wendy's

$17.64

-0.25 (-1.40%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Earnings
Wendy's sees FY19 adjusted EPS growth of 3.5%-7%, consensus 66c »

Sees FY19 global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Mar

BTX

BioTime

$1.16

-0.11 (-8.66%)

07:07
02/21/19
02/21
07:07
02/21/19
07:07
Initiation
BioTime initiated  »

BioTime initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 07

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.